Wararka shirkadda
-
Warar Xiiso Leh | JYMed's Liraglutide API Waxa uu Helaa Shahaadada WC
Oktoobar 12, 2024, JYMed's Liraglutide API wuxuu helay shahaado Xaqiijin qoran (WC), taasoo calaamad u ah tallaabo muhiim ah oo loo dhoofinayo guusha API ee suuqa EU. WC (Xaqiijin Qoraal ah)...Sii akhri -
Hambalyo JYMed's Tirzepatide oo Dhamaystiray Diiwaangelinta US-DMF
JYMed Technology Co., Ltd. waxay ku faraxsan tahay inay ku dhawaaqdo in badeecadeeda, Tirzepatide, ay si guul leh u dhamaystirtay diiwaangelinta Drug Master File (DMF) ee US FDA (Lambarka DMF: 040115) oo ay heshay aqoonsiga FDA ...Sii akhri -
JYMed Peptide wuxuu kugu martiqaadayaa inaad ka soo qaybgasho Bandhigga Walxaha Isku-qurxinta Kuuriya ee 2024
Goobta: Xarunta Bandhiga Caalamiga ah ee Kuuriya Taariikhda: Luulyo 24-26, 2024 Waqtiga: 10:00 subaxnimo - 5:00 galabnimo Ciwaanka: Xarunta Bandhiga COEX Hall C, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164 In-cosmetics waa hormuudka bandhiga caalamiga ah ee kooxda daryeelka shakhsi ahaaneedSii akhri
